{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T03:06:41Z","timestamp":1790651201406,"version":"4.1.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006364","name":"Institut National Du Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006364","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004097","name":"ARC Foundation for Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004097","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Forschung, Technologie und Raumfahrt","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004410","name":"T\u00fcrkiye Bilimsel ve Teknolojik Ara\u015ft\u0131rma Kurumu","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004410","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019920","name":"R\u00e9seau Soci\u00e9t\u00e9s d&apos;Acc\u00e9l\u00e9ration du Transfert de Technologies","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019920","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.phrs.2025.108035","type":"journal-article","created":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T02:35:11Z","timestamp":1763346911000},"page":"108035","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Immunomodulatory intraperitoneal chemotherapy with DACHPt-loaded biomaterial nanoparticles in colorectal carcinomatosis"],"prefix":"10.1016","volume":"222","author":[{"given":"Giuseppina","family":"Catania","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Zilio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoual","family":"Bakrin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Guerriero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Sidi-Boumediene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Chautard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myriam","family":"Kossai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrien","family":"Remaut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ragna","family":"Haegebaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Kryza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Lollo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.phrs.2025.108035_bib1","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"2","key":"10.1016\/j.phrs.2025.108035_bib2","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S1470-2045(20)30599-4","article-title":"Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial","volume":"22","author":"Qu\u00e9net","year":"2021","journal-title":"Lancet Oncol."},{"issue":"4","key":"10.1016\/j.phrs.2025.108035_bib3","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1515\/pp-2016-0027","article-title":"Randomized controlled trials evaluating cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in prevention and therapy of peritoneal metastasis: a systematic review","volume":"1","author":"Eveno","year":"2016","journal-title":"Pleura Perito"},{"issue":"24","key":"10.1016\/j.phrs.2025.108035_bib4","doi-asserted-by":"crossref","first-page":"5608","DOI":"10.1002\/cncr.25356","article-title":"Toward curative treatment of peritoneal carcinomatosis from nonovarian origin by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy: a multi-institutional study of 1,290 patients","volume":"116","author":"Glehen","year":"2010","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.phrs.2025.108035_bib5","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s00423-014-1253-z","article-title":"Morbidity, mortality, and oncological outcomes of 401 consecutive cytoreductive procedures with hyperthermic intraperitoneal chemotherapy (HIPEC)","volume":"400","author":"Desantis","year":"2015","journal-title":"Lange Arch. Surg."},{"key":"10.1016\/j.phrs.2025.108035_bib6","first-page":"1","article-title":"Actual 5-year survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for patients with peritoneal carcinomatosis of colorectal origin","author":"Sarfaty","year":"2023","journal-title":"Ann. Surg. Oncol."},{"issue":"1","key":"10.1016\/j.phrs.2025.108035_bib7","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-067691","article-title":"Nab-PIPAC: a phase IB study protocol of intraperitoneal cisplatin and nab-paclitaxel administered by pressurised intraperitoneal aerosol chemotherapy (PIPAC) in the treatment of advanced malignancies confined to the peritoneal cavity","volume":"13","author":"Lang","year":"2023","journal-title":"BMJ Open"},{"issue":"4","key":"10.1016\/j.phrs.2025.108035_bib8","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.ejso.2021.10.028","article-title":"Consensus guidelines for pressurized intraperitoneal aerosol chemotherapy: Technical aspects and treatment protocols: PIPAC practice guidelines","volume":"48","author":"H\u00fcbner","year":"2022","journal-title":"Eur. J. Surg. Oncol."},{"issue":"2","key":"10.1016\/j.phrs.2025.108035_bib9","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1515\/pp-2017-0015","article-title":"Experimental pharmacokinetics evaluation of chemotherapy delivery by PIPAC for colon cancer: first evidence for efficacy","volume":"2","author":"Eveno","year":"2017","journal-title":"Pleura Perito"},{"issue":"4","key":"10.1016\/j.phrs.2025.108035_bib10","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/codi.13130","article-title":"Pressurized intraperitoneal aerosol chemotherapy with oxaliplatin in colorectal peritoneal metastasis","volume":"18","author":"Demtr\u00f6der","year":"2016","journal-title":"Colorectal Dis."},{"issue":"12","key":"10.1016\/j.phrs.2025.108035_bib11","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1016\/j.ejso.2019.05.007","article-title":"Oxaliplatin use in pressurized intraperitoneal aerosol chemotherapy (PIPAC) is safe and effective: a multicenter study","volume":"45","author":"Sgarbura","year":"2019","journal-title":"Eur. J. Surg. Oncol."},{"issue":"1","key":"10.1016\/j.phrs.2025.108035_bib12","article-title":"Oxaliplatin: pre-clinical perspectives on the mechanisms of action, response and resistance","volume":"3","author":"Seetharam","year":"2009","journal-title":"Ecancermedicalscience"},{"key":"10.1016\/j.phrs.2025.108035_bib13","unstructured":"E. Raymond, S. Faivre, S. Chaney, J. Woynarowski, and E. Cvitkovic, \u201cCellular and Molecular Pharmacology of Oxaliplatin 1\u201d, Accessed: May 02, 2024. [Online]. Available: \u3008http:\/\/aacrjournals.org\/mct\/article-pdf\/1\/3\/227\/2222046\/gd0302000227.pdf\u3009."},{"key":"10.1016\/j.phrs.2025.108035_bib14","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.biomaterials.2016.06.032","article-title":"Inducing enhanced immunogenic cell death with nanocarrier-based drug delivery systems for pancreatic cancer therapy","volume":"102","author":"Zhao","year":"2016","journal-title":"Biomaterials"},{"issue":"6","key":"10.1016\/j.phrs.2025.108035_bib15","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/s41573-024-00920-9","article-title":"Targeting immunogenic cell stress and death for cancer therapy","volume":"23","author":"Galluzzi","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"issue":"6","key":"10.1016\/j.phrs.2025.108035_bib16","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/s41575-019-0126-x","article-title":"Immunotherapy in colorectal cancer: rationale, challenges and potential","volume":"16","author":"Ganesh","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"7","key":"10.1016\/j.phrs.2025.108035_bib17","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1093\/jnci\/89.7.480","article-title":"Pharmacokinetic problems in peritoneal drug administration: tissue penetration and surface exposure","volume":"89","author":"Dedrick","year":"1997","journal-title":"J. Natl. Cancer Inst."},{"issue":"7","key":"10.1016\/j.phrs.2025.108035_bib18","doi-asserted-by":"crossref","first-page":"736","DOI":"10.5152\/tjg.2023.22540","article-title":"Recurrence and postoperative death in patients with colorectal cancer: a new perspective via semi-competing risk framework","volume":"34","author":"Safari","year":"2023","journal-title":"Turk. J. Gastroenterol."},{"key":"10.1016\/j.phrs.2025.108035_bib19","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.addr.2016.07.001","article-title":"Nanomedicine-based intraperitoneal therapy for the treatment of peritoneal carcinomatosis - Mission possible?","volume":"108","author":"Dakwar","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"12","key":"10.1016\/j.phrs.2025.108035_bib20","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/nnano.2011.166","article-title":"Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size","volume":"6","author":"Cabral","year":"2011","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.phrs.2025.108035_bib21","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.jconrel.2014.06.042","article-title":"Progress of drug-loaded polymeric micelles into clinical studies","volume":"190","author":"Cabral","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.phrs.2025.108035_bib22","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ijbiomac.2014.01.054","article-title":"Oxaliplatin-chitosan nanoparticles induced intrinsic apoptotic signaling pathway: a \u2018smart\u2019 drug delivery system to breast cancer cell therapy","volume":"65","author":"Vivek","year":"2014","journal-title":"Int J. Biol. Macromol."},{"issue":"1","key":"10.1016\/j.phrs.2025.108035_bib23","article-title":"Preparation and in vivo evaluation of Dichloro(1,2-Diaminocyclohexane)platinum(II)-loaded core cross-linked polymer micelles","volume":"2012","author":"Oberoi","year":"2012","journal-title":"Chemother. Res Pr."},{"issue":"7","key":"10.1016\/j.phrs.2025.108035_bib24","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1158\/1078-0432.CCR-05-2169","article-title":"Preclinical efficacy and pharmacokinetics of AP5346, A novel diaminocyclohexane-platinum tumor-targeting drug delivery system","volume":"12","author":"Rice","year":"2006","journal-title":"Clin. Cancer Res."},{"issue":"5","key":"10.1016\/j.phrs.2025.108035_bib25","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1021\/bc0600517","article-title":"Synthesis and characterization of AP5346, a novel polymer-linked diaminocyclohexyl platinum chemotherapeutic agent","volume":"17","author":"Sood","year":"2006","journal-title":"Bioconjug Chem."},{"key":"10.1016\/j.phrs.2025.108035_bib26","unstructured":"G. Lollo, J. Benoit, and M. Brachet-Botineau, \u201cDrug delivery system,\u201d Google Patents, 2018, Accessed: Mar. 05, 2025. [Online]. Available: \u3008https:\/\/patents.google.com\/patent\/US12144896B2\/en\u3009."},{"issue":"3","key":"10.1016\/j.phrs.2025.108035_bib27","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.jconrel.2013.10.016","article-title":"In vivo biodistribution of siRNA and cisplatin administered using CD44-targeted hyaluronic acid nanoparticles","volume":"172","author":"Ganesh","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.phrs.2025.108035_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejpb.2020.02.008","article-title":"Bioinspired hyaluronic acid and polyarginine nanoparticles for DACHPt delivery","volume":"150","author":"Matha","year":"2020","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"26","key":"10.1016\/j.phrs.2025.108035_bib29","first-page":"29024","article-title":"Synergy between intraperitoneal aerosolization (PIPAC) and cancer nanomedicine: cisplatin-loaded polyarginine-hyaluronic acid nanocarriers efficiently eradicate peritoneal metastasis of advanced human ovarian cancer","volume":"12","author":"Shariati","year":"2020","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"1\u20133","key":"10.1016\/j.phrs.2025.108035_bib30","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jconrel.2004.08.022","article-title":"Preparation and biological properties of dichloro(1,2-diaminocyclohexane)platinum(II) (DACHPt)-loaded polymeric micelles","volume":"101","author":"Cabral","year":"2005","journal-title":"J. Control. Release"},{"key":"10.1016\/j.phrs.2025.108035_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2025.125532","article-title":"Generation of continuous production of polymeric nanoparticles via microfluidics for aerosolised localised drug delivery","author":"Catania","year":"2025","journal-title":"Int J. Pharm."},{"issue":"1","key":"10.1016\/j.phrs.2025.108035_bib32","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jphotobiol.2011.10.005","article-title":"Lifetime-based sensing of the hyaluronidase using fluorescein labeled hyaluronic acid","volume":"106","author":"Fudala","year":"2012","journal-title":"J. Photochem. Photobio. B"},{"issue":"7","key":"10.1016\/j.phrs.2025.108035_bib33","article-title":"Reporting animal research: explanation and elaboration for the arrive guidelines 2.0","volume":"18","author":"du Sert","year":"2020","journal-title":"PLoS Biol."},{"issue":"1","key":"10.1016\/j.phrs.2025.108035_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-022-10369-8","article-title":"Optimization of intraperitoneal aerosolized drug delivery using computational fluid dynamics (CFD) modeling","volume":"12","author":"Rahimi-Gorji","year":"2022","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.phrs.2025.108035_bib35","doi-asserted-by":"crossref","first-page":"906","DOI":"10.3390\/cancers11070906","article-title":"Aerosolization of nanotherapeutics as a newly emerging treatment regimen for peritoneal carcinomatosis","volume":"11","author":"Shariati","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.phrs.2025.108035_bib36","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jconrel.2024.10.011","article-title":"The journey of nanoparticles in the abdominal cavity: exploring their in vivo fate and impact factors","volume":"376","author":"Pan","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.phrs.2025.108035_bib37","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.ejpb.2021.05.024","article-title":"Freeze-drying of nanoparticles: how to overcome colloidal instability by formulation and process optimization","volume":"165","author":"Trenkenschuh","year":"2021","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.phrs.2025.108035_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.120826","article-title":"Microfluidic formulation of nanoparticles for biomedical applications","volume":"274","author":"Shepherd","year":"2021","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.phrs.2025.108035_bib39","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.nano.2009.03.002","article-title":"Design and development of ligand-appended polysaccharidic nanoparticles for the delivery of oxaliplatin in colorectal cancer","volume":"6","author":"Jain","year":"2010","journal-title":"Nanomedicine"},{"issue":"8","key":"10.1016\/j.phrs.2025.108035_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/pharmaceutics12080736","article-title":"Preparation and evaluation of intraperitoneal long-acting oxaliplatin-loaded multi-vesicular liposomal depot for colorectal cancer treatment","volume":"12","author":"Abuzar","year":"2020","journal-title":"Pharmaceutics"},{"issue":"3","key":"10.1016\/j.phrs.2025.108035_bib41","first-page":"254","article-title":"Oxaliplatin-induced acute renal failure presenting clinically as thrombotic microangiopathy: think of acute tubular necrosis","volume":"2","author":"Phan","year":"2009","journal-title":"NDT"},{"issue":"2","key":"10.1016\/j.phrs.2025.108035_bib42","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/1096-9098(200102)76:2<106::AID-JSO1020>3.0.CO;2-E","article-title":"Pharmacokinetics of intraperitoneal oxaliplatin: experimental studies","volume":"76","author":"Pestieau","year":"2001","journal-title":"J. Surg. Oncol."},{"key":"10.1016\/j.phrs.2025.108035_bib43","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.actbio.2023.08.027","article-title":"The effect of electrostatic high pressure nebulization on the stability, activity and ex vivo distribution of ionic self-assembled nanomedicines","volume":"170","author":"Braet","year":"2023","journal-title":"Acta Biomater."},{"issue":"18","key":"10.1016\/j.phrs.2025.108035_bib44","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.2217\/fon-2017-0145","article-title":"The colorectal cancer immune microenvironment and approach to immunotherapies","volume":"13","author":"Koi","year":"2017","journal-title":"Future Oncol."},{"issue":"3","key":"10.1016\/j.phrs.2025.108035_bib45","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.semcancer.2013.02.005","article-title":"Modulation of neutrophil granulocytes in the tumor microenvironment: mechanisms and consequences for tumor progression","volume":"23","author":"Dumitru","year":"2013","journal-title":"Semin Cancer Biol."},{"key":"10.1016\/j.phrs.2025.108035_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106197","article-title":"Targeting T regulatory cells: their role in colorectal carcinoma progression and current clinical trials","volume":"178","author":"Bandaru","year":"2022","journal-title":"Pharm. Res"},{"issue":"1","key":"10.1016\/j.phrs.2025.108035_bib47","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.tice.2016.11.004","article-title":"The histophysiology and pathophysiology of the peritoneum","volume":"49","author":"van Baal","year":"2017","journal-title":"Tissue Cell"},{"issue":"8","key":"10.1016\/j.phrs.2025.108035_bib48","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15082383","article-title":"Immunotherapy for Peritoneal Carcinomatosis: challenges and prospective outcomes","volume":"15","author":"Ornella","year":"2023","journal-title":"Cancers"},{"issue":"13","key":"10.1016\/j.phrs.2025.108035_bib49","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1038\/s41388-018-0581-9","article-title":"Cisplatin-induced immune modulation in ovarian cancer mouse models with distinct inflammation profiles","volume":"38","author":"Grabosch","year":"2019","journal-title":"Oncogene"},{"key":"10.1016\/j.phrs.2025.108035_bib50","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.addr.2020.10.015","article-title":"Intraperitoneal aerosolized drug delivery: technology, recent developments, and future outlook","volume":"160","author":"Rahimi-Gorji","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"7","key":"10.1016\/j.phrs.2025.108035_bib51","doi-asserted-by":"crossref","first-page":"e368","DOI":"10.1016\/S1470-2045(19)30318-3","article-title":"Pressurised intraperitoneal aerosol chemotherapy: rationale, evidence, and potential indications","volume":"20","author":"Alyami","year":"2019","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.phrs.2025.108035_bib52","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ejpb.2022.01.002","article-title":"Nanoparticle mediated targeting of toll-like receptors to treat colorectal cancer","volume":"172","author":"Haegebaert","year":"2022","journal-title":"Eur. J. Pharm. Biopharm."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661825004608?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661825004608?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T10:04:09Z","timestamp":1773828249000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661825004608"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":52,"alternative-id":["S1043661825004608"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2025.108035","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunomodulatory intraperitoneal chemotherapy with DACHPt-loaded biomaterial nanoparticles in colorectal carcinomatosis","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2025.108035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108035"}}